170 related articles for article (PubMed ID: 19127251)
1. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
Joo KM; Park IH; Shin JY; Jin J; Kang BG; Kim MH; Lee SJ; Jo MY; Kim SU; Nam DH
Mol Ther; 2009 Mar; 17(3):570-5. PubMed ID: 19127251
[TBL] [Abstract][Full Text] [Related]
2. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
4. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
[TBL] [Abstract][Full Text] [Related]
5. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
7. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.
Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC
Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer.
Yi BR; Kim SU; Choi KC
Oncotarget; 2016 Feb; 7(5):5985-99. PubMed ID: 26716512
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
[TBL] [Abstract][Full Text] [Related]
12. Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells.
Shin HJ; Hwang KA; Go RE; Kim SU; Choi KC
J Cell Biochem; 2020 Feb; 121(2):1586-1598. PubMed ID: 31512776
[TBL] [Abstract][Full Text] [Related]
13. The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models.
Park GT; Heo JR; Kim SU; Choi KC
Cytotherapy; 2018 Sep; 20(9):1191-1201. PubMed ID: 30078654
[TBL] [Abstract][Full Text] [Related]
14. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
[TBL] [Abstract][Full Text] [Related]
15. Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.
Yi BR; Kim SU; Choi KC
Int J Oncol; 2015 Jul; 47(1):171-8. PubMed ID: 25963746
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer.
Seol HJ; Jin J; Seong DH; Joo KM; Kang W; Yang H; Kim J; Shin CS; Kim Y; Kim KH; Kong DS; Lee JI; Aboody KS; Lee HJ; Kim SU; Nam DH
Cancer Lett; 2011 Dec; 311(2):152-9. PubMed ID: 21868150
[TBL] [Abstract][Full Text] [Related]
17. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
18. Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells.
Kwon SK; Kim SU; Song JJ; Cho CG; Park SW
Clin Exp Otorhinolaryngol; 2013 Sep; 6(3):176-83. PubMed ID: 24069522
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
Kim JH; Kim JY; Kim SU; Cho KG
Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]